International reference pricing is a method used by countries to determine the reimbursement price of pharmaceutical products. The process involves comparing the prices of a drug in different countries and using that information to set the reimbursement price in a particular country.
IRP can impact market access as a lower reimbursement price may reduce the profitability of a drug in a specific market and limit the company's ability to sell at a competitive price. In some cases, the lower reimbursement price may even make it uneconomical for the company to sell the drug in that market, effectively limiting access. As such, IRP is a significant factor that companies must consider when developing their market access strategies.
Considering IRP is vital to gain a holistic, realistic and global perspective on a products revenue and ultimate success.
Failing to consider IRP in pricing and market access strategies can impede a company's chances of attaining sustainable access. However, accurately assessing IRP's impact is a complex task that requires expertise.
Golden Triangle Consultants are IRP experts with extensive experience in IRP modelling and successful integration into pricing and market access strategies.
Using a model in IRP assessments helps to provide a consistent and transparent basis for pricing and market access decisions, reducing the risk of incorrect or incomplete comparisons and allowing for a more accurate assessment of a product's potential revenue. However, due to the complexities involved in IRP, generic and 'out of the box' models can often do more harm than good.
GTC Specialise in providing the right modelling approach for our clients market access and pricing challenges. From rapid competitor IRP assessment to full Gross to Net portfolio implementation, our tools are tailored to your needs.
IRP is no exact science and is influenced by non-quantifiable events. At GTC modelling goes hand in hand with our comprehensive in-market IRP knowledge and product specific research to give outputs realistic of real life.
Our services often go far beyond a standalone IRP model. We have worked with companies to effectively embed IRP withing their strategic planning and forecasting processes and create feedback loops and pressure testing for payer research.
The wrong launch sequence could unintentionally set a price benchmark that can never be recovered, and causing unintentional market access impacts on other markets
A price that makes commercial sense in one market my have significant negative cascading impacts in others
Entering into a price war with generics to maintain sales in one market could cause price and revenue erosion in others with no generic competition
Our team of experts is dedicated to delivering tailored and innovative IRP solutions to meet the unique needs of our clients. In these case studies, we showcase two of our IRP projects that demonstrate our ability to provide full-scale build and implementation as well as rapid assessments of IRP impacts.
These projects highlight the diverse and flexible nature of our IRP solutions and our commitment to delivering value to our clients.
The Problem:
A major pharmaceutical firm was grappling with the inefficiency of their manual International Reference Pricing (IRP) assessments due to the complex and dynamic nature of the international pricing landscape. They were seeking a comprehensive solution that would allow them to gain a clearer and more precise understanding of their pricing data, and enhance their revenue forecasting accuracy. The system had to integrate with their price management system and feed into their strategic planning processes.
The Solution:
Golden Triangle Consultants was engaged to provide a full build and implementation of an IRP model that would cover the entire portfolio of the client. The solution was designed to integrate data from multiple internal and external systems, including list and net price data, sale figures and Cost of Goods data. The model was also designed to be flexible and adaptable, allowing the client to easily update it with new data as the market evolved.
As a result of the project, the client was able to forecast global IRP price changes for their products over a 5-year time horizon. This more accurate and comprehensive view of their global pricing landscape allowed them to make more informed decisions about their pricing strategy and revenue forecasting.
The Problem:
A pharmaceutical company was facing a high level of uncertainty and risk as a result of an unexpected decrease in a competitor products price in a particular market. The company sought a rapid assessment of the competitor's global price evolution based on International Reference Pricing and the impacts that this IRP cascades would have on the pricing, market access and revenue potential of their product.
The Solution:
Golden Triangle Consultants conducted a Rapid IRP Assessment using their in-house IRP model. The model forecasted the global list price evolution of the competitor's product over the next 5 years and identified any IRP driven price decreases as a result of the original price cut.
The outputs of the model allowed the client to quickly and accurately assess the impact of the competitor's price change on the pricing and revenue strategies for their own product. The follow-up scenario analysis conducted by Golden Triangle Consultants painted a clear picture of how future price cuts could shape the market, allowing the client to proactively prepare and react to any potential changes.
Copyright © 2024 Golden Triangle Consultants - All Rights Reserved.